First outcome results after total knee and hip replacement from the Lithuanian arthroplasty register
Šarūnas Tarasevičius +5 more
openalex +1 more source
The composite vastus medialis–patellar complex osseomuscular flap as a salvage procedure after complex trauma of the knee—an anatomical study and clinical application [PDF]
Elias Polykandriotis +6 more
openalex +1 more source
The “gut‐joint axis” in knee synovitis is uncovered. Integrated multi‐omics studies are conducted in two independent osteoarthritis cohorts. Synovitis is characterized an increased F/B ratio, as well as alterations of 3‐HIA, geranic acid, and TWEAK. Upregulated TWEAK receptor is found in high‐grade synovitis, and inversely correlated with lower TWEAK ...
Xiaoshuai Wang +22 more
wiley +1 more source
Insomnia and progression to total joint replacement in hip (41 737) and knee pain (81 958): a prospective UK biobank cohort study. [PDF]
Haber T +7 more
europepmc +1 more source
Salmonella entericaSerotype Choleraesuis Infection of the Knee and Femur in a Nonbacteremic Diabetic Patient [PDF]
Alexander M. Sy +2 more
openalex +1 more source
The loss of Ubiquitin Specific Peptidase 26 (USP26) in osteoblasts results in decreased bone formation, as well as multi‐organ fibrosis associated with insulin resistance (IR). Mechanistically, the absence of USP26 reduces glycolysis and lactate accumulation, leading to decreased histone H3 lysine 18 lactylation (H3K18LA) in the promoter region of KH ...
Jiyuan Tang +9 more
wiley +1 more source
Age, Workload, and Usage Rate: Risk Factors Associated With Knee Injuries in Women's National Basketball Association Athletes. [PDF]
Menon S +5 more
europepmc +1 more source
A Rationally Engineered Spleen‐Tropic One‐Component Lipid‐mRNA Complex (OncoLRC) for Cancer Vaccines
OncoLRC, a one‐component lipid‐mRNA complex, enables efficient spleen‐targeted delivery at an exceptionally low lipid‐to‐mRNA mass ratio (1.5:1), robustly activates immune responses, inhibits tumor growth, and synergizes with checkpoint blockade, presenting a next‐generation platform for mRNA vaccines.
Qimeng Yin +4 more
wiley +1 more source

